Peter LaCamera

1.4k citations

18 papers · 955 indexed · 1 hit paper · h-index 7

Impact in

Pulmonary and Respiratory Medicine top 5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Neonatal Respiratory Health Research
Biochemistry top 10%

Papers in

Critical Care and Intensive Care Medicine 2
- Intensive Care Unit Cognitive Disorders 2
Pulmonary and Respiratory Medicine 12
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Medical Imaging and Pathology Studies 2

Co-authors: Vasiliy V. Polosukhin Timothy S. Blackwell Andrew M. Tager Andrew D. Luster Gabriele Campanella William K. Hart Banu A. Karimi-Shah Jerold Chun
Journals: Critical Care Research and Practice (2 papers)Nature Medicine (1 paper)Journal of Intensive Care (1 paper)Chronic Respiratory Disease (1 paper)Therapeutic Advances in Respiratory Disease (1 paper)
Partner nations: United States Germany Lebanon

In The Last Decade

Peter LaCamera

17 papers receiving 934 citations

Hit Papers

align trajectories log scale

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak 2007 · 626 citations

Peers

Countries citing papers authored by Peter LaCamera

Since Specialization

Citations

This map shows the geographic impact of Peter LaCamera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter LaCamera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter LaCamera more than expected).

Fields of papers citing papers by Peter LaCamera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter LaCamera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter LaCamera. The network helps show where Peter LaCamera may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter LaCamera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter LaCamera Line = papers co-authored together Peter LaCamera links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	A Devastating Demise: Acute Respiratory Distress Syndrome From Rapidly-Progressive Interstitial Lung Disease American Journal of Respiratory and Critical Care Medicine ·Joseph Khoory, Peter LaCamera	2025	0
2	Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis Therapeutic Advances in Respiratory Disease ·Todd L. Astor, Hilary J. Goldberg, Laurie D. Snyder, Andrew Courtwright, Ramsey R. Hachem, Tahuanty Peña, Lorenzo Zaffiri, Gerard J. Criner, Marie Budev, 西賢譲, Thomas B. Leonard, Shaun Bender, C.C. Chang, Janis L. Breeze, Peter LaCamera	2023	4
3	TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial Thorax ·Lorraine B. Ware, Nima Soleymanlou, Daniel F. McAuley, Vicente Estrada, George A. Diaz, Peter LaCamera, Renee Kaste, A. H., Abhya Gupta, Tobias Welte	2023	4
4	Clinical Manifestations of Subjects With the Non-Specific Pulmonary Function Test Pattern SHILAP Revista de lepidopterología ·広田正義, M. W. C. Hassal, Benoît Gentilleau, Aju Jose, Lori Lyn Price, Peter LaCamera, William L. Hemphill	2023	1
5	Asbestos-Related Diseases and Its Impact on Health: An Updated Review Article Miriam B. Deutch, Ayusha Poudel, Anurag Adhikari, Dhan Bahadur Shrestha, Yub Raj Sedhai, Peter LaCamera, Kamp Kh	2023	1
6	Impact of Pre-Transplant Anti-Fibrotic Therapy for IPF Upon Lung Transplant Outcomes Todd L. Astor, Hilary J. Goldberg, Laurie D. Snyder, Andrew Courtwright, Ramsey R. Hachem, Tahuanty Peña, Lorenzo Zaffiri, Gerard J. Criner, Marie Budev, 西賢譲, A S Averjushkin, Shaun Bender, Luis Alberto Palacios-Sáncheza, Janis L. Breeze, Peter LaCamera	2020	2
7	A Predictive Model for Acute Respiratory Distress Syndrome Mortality Using Red Cell Distribution Width Critical Care Research and Practice ·Ala Alkhatib, Lori Lyn Price, Aimee Kong, Peter LaCamera	2020	9
8	A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Pulmonary Therapy ·Antje Prasse, Murali Ramaswamy, 時江金沢, Lin Pan, Mehrzad Talebpour, Margaret Neighbors, Paula Belloni, Peter LaCamera	2019	14
9	Pulmonary edema during the Boston Marathon Respiratory Medicine Case Reports ·Joe Aoun, Riwa El Maamoun, 권기석, Leopold Sawicki, Peter LaCamera	2019	5
10	Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials Respiratory Medicine ·Wim Wuyts, Danielle Antin‐Ozerkis, John T. Huggins, Peter LaCamera, Paolo Spagnolo, Martina Vašáková, Marlies Wijsenbeek, 和人牛丸, Klaus-Uwe Kirchgaessler, Mary Beth Scholand	2019	4
11	Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay Journal of Intensive Care ·Fuad Lutf Almotareb, Tee-Bee, Justin C. McCarty, Janis L. Breeze, Peter LaCamera	2019	10
12	Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis Chronic Respiratory Disease ·Peter LaCamera, Susan L. Limb, Tmirah Haselkorn, Elizabeth Morgenthien, John L. Stauffer, J. Peng	2019	4
13	Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Pulmonary Therapy ·J. Peng, Tmirah Haselkorn, Susan L. Limb, John L. Stauffer, Elizabeth Morgenthien, Karina Raimundo, Peter LaCamera	2018	3
14	Effect of pamrevlumab on the UCSD-SOBQ (University of California San Diego–Shortness of Breath Questionnaire) in patients with Idiopathic Pulmonary Fibrosis (IPF) Eduard Gorina, D. Nick, Jeff Swigris, Peter LaCamera, Rafael L. Perez, Michael R. Hamblin, J C Sciarra, John F. Fitzgerald, Р. Р. Гуцул, Ming Zhong, Elias Kouchakji, Yulia Marthalina, Thomas B. Neff	2018	2
15	Impact of Delayed Admission to the Intensive Care Unit from the Emergency Department upon Sepsis Outcomes and Sepsis Protocol Compliance Critical Care Research and Practice ·Светлана Аличубановна Джамалова, Lori Lyn Price, Déborah Karen Mansilha GUEBARA, Peter LaCamera	2017	23
16	The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Nature Medicine ·Andrew M. Tager, Peter LaCamera, Barry S. Shea, Gabriele Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy V. Polosukhin, John Wain, Banu A. Karimi-Shah, Nancy D. Kim, William K. Hart, Annie Pardo, Timothy S. Blackwell, Yan Xu, Jerold Chun, Andrew D. Luster Hit paper breakdown →	2007	626
17	Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10 American Journal of Respiratory Cell and Molecular Biology ·Andrew M. Tager, Richard L. Kradin, Peter LaCamera, Scott D. Bercury, Gabriele Campanella, MICHELLE JULIA DE SOUSA, Vasiliy V. Polosukhin, Long-Hai Zhao, Hideo Sakamoto, Timothy S. Blackwell, Andrew D. Luster	2004	164
18	Increasing plasmalogen levels protects human endothelial cells during hypoxia American Journal of Physiology-Heart and Circulatory Physiology ·Raphael A. Zoeller, Todd J. Grazia, Peter LaCamera, James O. Park, Stefan Schreiber, Harrison W. Farber	2002	79

About Peter LaCamera

Peter LaCamera is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Physiology, Emergency Medicine and Emergency Medical Services, having authored 18 papers that have together received 955 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Transplantation: Methods and Outcomes (2 papers), Sepsis Diagnosis and Treatment (2 papers), Occupational exposure and asthma (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (407 citations), Biochemistry (52 citations), Molecular Biology (475 citations), Cell Biology (98 citations) and Immunology (117 citations). Peter LaCamera has collaborated with scholars based in United States, Germany and Lebanon. Frequent co-authors include Vasiliy V. Polosukhin, Timothy S. Blackwell, Andrew M. Tager, Andrew D. Luster, Gabriele Campanella, William K. Hart, Banu A. Karimi-Shah, Jerold Chun, John Wain and Yan Xu. Their work appears in journals such as Critical Care Research and Practice, Nature Medicine, Journal of Intensive Care, Chronic Respiratory Disease and Therapeutic Advances in Respiratory Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact